HER2-positive breast cancer patients receiving trastuzumab treatment obtain prognosis comparable with that of HER2-negative breast cancer patients

PURPOSE: The efficacy of trastuzumab in Chinese breast cancer (BC) patients has rarely been reported. This study was designed to compare the clinical outcomes of HER2-positive BC patients receiving or not receiving trastuzumab treatment and HER2-negative BC patients. PATIENTS AND METHODS: This study...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Qin, Tao, Yuan, Zhongyu, Peng, Roujun, Bai, Bing, Shi, Yanxia, Teng, Xiaoyu, Liu, Donggeng, Wang, Shusen
Format: Artigo
Idioma:Inglês
Publicat: Dove Medical Press 2013
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3626365/
https://ncbi.nlm.nih.gov/pubmed/23630425
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S40851
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars